Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Patient Education
Share your love
Amring Names Dr. Donnenfeld as U.S. Advisory Board Chair
Amring Pharmaceuticals Inc., a subsidiary of Nordic Group B.V., announced the appointment of Dr. Eric D. Donnenfeld, a distinguished figure in ophthalmology, as the Chair of its U.S. Medical Advisory Board (MAB). This strategic decision comes as the company gears…
SAV-IOL Launches Enhanced Toric Calculator Features
Swiss Advanced Vision (SAV-IOL) announced the introduction of new features to its toric calculator, aimed at revolutionizing the way ophthalmologists approach astigmatism correction surgeries. The newly released web-based configurator marks a significant advancement in surgical planning, offering unparalleled precision in…
AI’s Superiority in Diagnosing Glaucoma & Retinal Diseases
A study conducted at the New York Eye and Ear Infirmary of Mount Sinai (NYEE) demonstrates that a large language model (LLM) AI system, specifically GPT-4 (Generative Pre-Training–Model 4) from OpenAI, can rival, and in some cases surpass, human ophthalmologists…
Ophthalmology In Ancient Egyptian & Greek Mythology I OBN
The Brightness of Divine Glance In Ancient Egypt One of the first civilizations in human history is that of ancient Egypt. The pioneering work of the ancient Egyptians in the domains of art, medicine, and the mythological storytelling of scientific…
Squamous Blepharitis: Causes, Symptoms and Treatment
Squamous blepharitis is a condition characterized by inflammation of the eyelids, specifically affecting the squamous or outermost layer of the eyelid margin. This condition can have a significant impact on eye health, causing symptoms such as redness, itching, and irritation…
Dry Eye Disease in Postmenopausal Women
A common ocular problem is dry eye syndrome. Women are more likely to acquire dry eye syndrome and its accompanying detrimental implications on their general eye health, especially menopausal women with comorbidities. One of the most common ocular disorders is…
VSY Biotechnology Aims for Great Place to Work® Certification
VSY Biotechnology GmbH, a leader in the biotechnology sector based in Leinfelden-Echterdingen, Germany, announced a key strategic partnership with Great Place to Work®, the worldwide authority on workplace culture and employee satisfaction. This collaboration is a testament to VSY Biotechnology’s…
AbbVie Appoints Robert A. Michael as CEO
AbbVie announced that Robert A. Michael will take the helm as the company’s next Chief Executive Officer (CEO), succeeding Richard A. Gonzalez. This transition is set to take effect on July 1, 2024, marking a new chapter in the company’s…
Innovent’s Phase 3 TED Treatment Success in China
Innovent Biologics announced the successful achievement of the primary endpoint in the phase 3 registrational study, RESTORE-1, of IBI311 in China. This recombinant anti-insulin-like growth factor 1 receptor (IGF-1R) antibody marks a pivotal advancement in the treatment of thyroid eye…
Eversight Partners with Emmecell for Ocular Therapy Advances
Eversight, a leading non-profit dedicated to the restoration of sight through the recovery, processing, and distribution of corneal tissue, announced a strategic partnership with Emmecell Biotech, a biotechnology company focused on developing novel cell therapies for ocular diseases. This collaboration…